More good than harm should be expected when Testi-ICSI is applied to oligozoospermic men with post-testicular sperm DNA fragmentation. Editorial Article
Overview
publication date
- September 1, 2017
published in
Identity
PubMed Central ID
- PMC5643725
Scopus Document Identifier
- 85030449050
Digital Object Identifier (DOI)
- 10.21037/tau.2017.03.22
PubMed ID
- 29082983
Additional Document Info
has global citation frequency
volume
- 6
issue
- Suppl 4